BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2021 9:58:01 AM | Browse: 388 | Download: 568
 |
Received |
|
2021-01-13 18:33 |
|
Peer-Review Started |
|
2021-01-13 18:34 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-13 08:24 |
|
Revised |
|
2021-02-24 21:36 |
|
Second Decision |
|
2021-04-26 10:06 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-04-26 10:27 |
|
Articles in Press |
|
2021-04-26 10:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-05-05 11:25 |
|
Typeset the Manuscript |
|
2021-05-20 13:19 |
|
Publish the Manuscript Online |
|
2021-05-26 09:58 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Non-alcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Musaab Ahmed and Mohamed H Ahmed |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamed H Ahmed, MBBS, PhD, Doctor, Department of Medicine and HIV metabolic clinic, Milton Keynes University Hospital NHS Foundation Trust, Eaglestone, Milton Keynes MK5 6LD, United Kingdom. mohamed.hassan-ahmed@mkuh.nhs.uk |
| Key Words |
Fatty liver; COVID-19; Diabetes; Obesity and pandemic |
| Core Tip |
The earlier studies suggested that most vulnerable individuals to severe acute respiratory syndrome coronavirus 2 infection suffer from pre-existing disease, including non-alcoholic fatty liver disease (NAFLD). There is an interwoven relationship between NAFLD and the associated high-risk factors for coronavirus disease 2019 (COVID-19). NAFLD can increase risk of infection, lung injury, cardiac impairment and difficulty with respiratory ventilation and can be associated with higher risk for COVID-19 especially in presence of liver fibrosis. The association between high production of interleukin- 6 in both NAFLD and COVID-19 may raise the need for further research in whether NAFLD can directly be involved in the cytokine storms. |
| Publish Date |
2021-05-26 09:58 |
| Citation |
Ahmed M, Ahmed MH. Non-alcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic. World J Clin Cases 2021; 9(17): 4133-4142 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i17/4133.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i17.4133 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
